BIOMAT Database Logo BIOMAT Database Logo

[Pharmacokinetics of digitoxin in patients with liver cirrhosis]. 1978

U Peters, and W P Fritsch, and B Grabensee

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D004074 Digitoxin A cardiac glycoside sometimes used in place of DIGOXIN. It has a longer half-life than digoxin; toxic effects, which are similar to those of digoxin, are longer lasting. (From Martindale, The Extra Pharmacopoeia, 30th ed, p665) Coramedan,Digimed,Digimerck,Digitaline Nativelle,Digitoxin AWD,Digitoxin Bürger,Digitoxin Didier,Digitoxin-Philo,Digophton,AWD, Digitoxin,Bürger, Digitoxin,Didier, Digitoxin,Digitoxin Philo,Nativelle, Digitaline
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

U Peters, and W P Fritsch, and B Grabensee
Digitoxin and its metabolites in patients with liver cirrhosis.
January 1993, European journal of drug metabolism and pharmacokinetics,
U Peters, and W P Fritsch, and B Grabensee
Fleroxacin pharmacokinetics in patients with liver cirrhosis.
March 1992, Antimicrobial agents and chemotherapy,
U Peters, and W P Fritsch, and B Grabensee
[Ibuprofen pharmacokinetics in patients with liver cirrhosis].
June 1982, Wiadomosci lekarskie (Warsaw, Poland : 1960),
U Peters, and W P Fritsch, and B Grabensee
Pancuronium pharmacokinetics in patients with liver cirrhosis.
November 1978, British journal of anaesthesia,
U Peters, and W P Fritsch, and B Grabensee
Pharmacokinetics of miocamycin in patients with liver cirrhosis.
January 1989, Chemotherapy,
U Peters, and W P Fritsch, and B Grabensee
Pharmacokinetics of ciprofloxacin in patients with liver cirrhosis.
January 2002, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology,
U Peters, and W P Fritsch, and B Grabensee
[Pharmacokinetics of metoxypropriocin in patients with liver cirrhosis].
January 1982, Przeglad lekarski,
U Peters, and W P Fritsch, and B Grabensee
Pharmacokinetics of metoclopramide in patients with liver cirrhosis.
February 1991, British journal of clinical pharmacology,
U Peters, and W P Fritsch, and B Grabensee
Pharmacokinetics of diltiazem in patients with liver cirrhosis.
January 1990, International journal of clinical pharmacology research,
U Peters, and W P Fritsch, and B Grabensee
Pharmacokinetics of diacerein in patients with liver cirrhosis.
July 1993, Biopharmaceutics & drug disposition,
Copied contents to your clipboard!